$2.25 Billion is the total value of SCOPIA CAPITAL MANAGEMENT LP's 24 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 66.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VST | Sell | VISTRA ENERGY CORP | $266,892,000 | -22.5% | 11,788,503 | -10.9% | 11.85% | -6.8% |
| SPR | Buy | SPIRIT AEROSYSTEMS HLDGS INC | $208,659,000 | -0.0% | 2,564,326 | +12.5% | 9.27% | +20.2% |
| ITRI | Sell | ITRON INC | $203,992,000 | -5.5% | 3,260,227 | -29.5% | 9.06% | +13.7% |
| SPY | Buy | SPDR S&P 500 ETF TRput | $177,148,000 | +15.7% | 604,600 | +11.5% | 7.87% | +39.1% |
| JCI | Sell | JOHNSON CTLS INTL PLC | $165,687,000 | -34.9% | 4,010,813 | -41.8% | 7.36% | -21.8% |
| IWM | New | ISHARES TRput | $145,035,000 | – | 932,700 | +100.0% | 6.44% | – |
| ETRN | Sell | EQUITRANS MIDSTREAM CORPORAT | $133,705,000 | -26.4% | 6,783,588 | -18.7% | 5.94% | -11.5% |
| SRC | Buy | SPIRIT RLTY CAP INC NEW | $114,983,000 | +12.0% | 2,695,324 | +4.3% | 5.11% | +34.7% |
| HZNP | New | HORIZON THERAPEUTICS PUB LTD | $103,181,000 | – | 4,288,487 | +100.0% | 4.58% | – |
| VG | Buy | VONAGE HLDGS CORP | $99,277,000 | +14.1% | 8,762,269 | +1.1% | 4.41% | +37.2% |
| WBT | Buy | WELBILT INC | $96,274,000 | +183.9% | 5,764,889 | +178.5% | 4.28% | +241.5% |
| IAA | New | IAA INC | $89,906,000 | – | 2,318,366 | +100.0% | 3.99% | – |
| NXPI | New | NXP SEMICONDUCTORS N V | $87,332,000 | – | 894,704 | +100.0% | 3.88% | – |
| RTRX | Sell | RETROPHIN INC | $78,043,000 | -18.2% | 3,884,691 | -7.8% | 3.47% | -1.6% |
| ZGNX | Sell | ZOGENIX INC | $68,051,000 | -35.3% | 1,424,247 | -25.5% | 3.02% | -22.2% |
| KAR | Buy | KAR AUCTION SVCS INC | $64,140,000 | +18.8% | 2,565,615 | +143.9% | 2.85% | +42.9% |
| PTCT | Sell | PTC THERAPEUTICS INC | $44,235,000 | -44.2% | 983,005 | -53.3% | 1.96% | -32.9% |
| HHR | New | HEADHUNTER GROUP PLCsponsored ads | $35,534,000 | – | 2,186,732 | +100.0% | 1.58% | – |
| HLIT | Buy | HARMONIC INC | $33,816,000 | +116.8% | 6,092,937 | +111.7% | 1.50% | +160.8% |
| ACOR | Sell | ACORDA THERAPEUTICS INC | $25,491,000 | -57.0% | 3,323,456 | -25.5% | 1.13% | -48.3% |
| FOSL | New | FOSSIL GROUP INC | $4,553,000 | – | 395,925 | +100.0% | 0.20% | – |
| ICPT | New | INTERCEPT PHARMACEUTICALS IN | $4,519,000 | – | 56,794 | +100.0% | 0.20% | – |
| MNKD | New | MANNKIND CORP | $1,074,000 | – | 933,612 | +100.0% | 0.05% | – |
| AMSC | AMERICAN SUPERCONDUCTOR CORP | $182,000 | -27.8% | 19,610 | 0.0% | 0.01% | -11.1% | |
| LJPC | Exit | LA JOLLA PHARMACEUTICAL CO | $0 | – | -480,000 | -100.0% | -0.11% | – |
| PRTA | Exit | PROTHENA CORP PLC | $0 | – | -600,000 | -100.0% | -0.27% | – |
| YMAB | Exit | Y MABS THERAPEUTICS INC | $0 | – | -920,282 | -100.0% | -0.89% | – |
| IMMU | Exit | IMMUNOMEDICS INC | $0 | – | -1,937,843 | -100.0% | -1.38% | – |
| ISBC | Exit | INVESTORS BANCORP INC NEW | $0 | – | -7,224,672 | -100.0% | -3.16% | – |
| GWPH | Exit | GW PHARMACEUTICALS PLCads | $0 | – | -749,538 | -100.0% | -4.67% | – |
| HZNP | Exit | HORIZON PHARMA PLC | $0 | – | -8,159,184 | -100.0% | -7.96% | – |
| JD | Exit | JD COM INCspon adr cl a | $0 | – | -7,207,601 | -100.0% | -8.03% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPIRIT AEROSYSTEMS HLDGS INC | 39 | Q4 2022 | 28.3% |
| SPDR S&P 500 ETF TR | 31 | Q3 2023 | 16.9% |
| ISHARES TR | 28 | Q3 2023 | 10.9% |
| MANNKIND CORP | 24 | Q3 2023 | 0.5% |
| BAIDU INC | 21 | Q2 2018 | 8.6% |
| ITRON INC | 21 | Q3 2020 | 12.1% |
| RETROPHIN INC | 20 | Q3 2020 | 4.5% |
| HARMONIC INC | 19 | Q3 2023 | 10.5% |
| JOHNSON CTLS INTL PLC | 17 | Q3 2020 | 9.6% |
| ACORDA THERAPEUTICS INC | 17 | Q3 2019 | 4.0% |
View SCOPIA CAPITAL MANAGEMENT LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| VERRA MOBILITY Corp | October 28, 2022 | 6,710,074 | 4.4% |
| Spirit AeroSystems Holdings, Inc. | February 14, 2022 | 2,084,212 | 2.0% |
| Retrophin, Inc. | February 14, 2020 | 2,011,697 | 4.7% |
| Horizon Therapeutics Public Ltd Co | January 10, 2020 | 2,527,456 | 1.4% |
| ZOGENIX, INC. | January 10, 2020 | 919,484 | 2.1% |
| ITRON, INC. | January 07, 2020 | 1,808,059 | 4.6% |
| ACORDA THERAPEUTICS INCSold out | November 12, 2019 | 0 | 0.0% |
| LA JOLLA PHARMACEUTICAL CO | April 10, 2019 | 480,000 | 1.8% |
| Prothena Corp plc | March 11, 2019 | 1,883,816 | 4.7% |
| GW PHARMACEUTICALS PLC | February 14, 2019 | 1,345,198 | 4.6% |
View SCOPIA CAPITAL MANAGEMENT LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D | 2024-04-26 |
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13D/A | 2024-01-22 |
| 13F-HR/A | 2023-11-14 |
| 13F-HR | 2023-11-14 |
| SC 13D | 2023-09-21 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13D/A | 2023-04-12 |
View SCOPIA CAPITAL MANAGEMENT LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.